MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202611110723 A) filed by Shree Guru Gobind Singh Tricentenary University on September 15, 2026, for Ayurvedic Intracanal Medicament Formulation For Treatment Of Polymicrobial Endodontic Infections And Method For Preparation Thereof.
Inventors include Dr. Shalu; Dr. Rekha Phull; Dr. Mukesh Sharma; Dr. Leimapokpam Sumitra Devi; and Dr. Satakshi Bhattacharjee.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: An Ayurvedic intracanal medicament formulation for treatment of polymicrobial endodontic infections comprising, a Neem (Azadirachta indica) extract, a Tulsi (Ocimum tenuiflorum) extract and a Haridra (Curcuma longa) extract wherein the Neem extract, Tulsi extract and Haridra extract are present in substantially equal proportions to form a homogenous formulation suitable for intracanal administration, the formulation exhibits antimicrobial activity against at least Streptococcus mutans, Enterococcus faecalis, and Candida albicans. The formulation comprises of Neem extract, Tulsi extract and Haridra extract in a weight ratio of 1:1:1. The formulation is free from synthetic antibiotics and configured for intracanal placement during endodontic treatment. A method of preparing an Ayurvedic intracanal medicament formulation comprising the steps: preparing Neem extract, Tulsi extract and Haridra extract, separately dispensing each extract in sterile distilled water, vortex mixing each dispersion, combining the dispersions in substantially equal proportions and mixing until a homogeneous formulation is obtained.
Disclaimer: Curated by HT Syndication.
